Subtopic Deep Dive
Immunophilins in Calcineurin Inhibition
Research Guide
What is Immunophilins in Calcineurin Inhibition?
Immunophilins in Calcineurin Inhibition refers to the mechanism where cyclophilin-cyclosporin A and FKBP-FK506 complexes bind and block calcineurin phosphatase activity to suppress T-cell signaling in immune responses.
Cyclosporin A binds cyclophilin, and FK506 binds FKBP12, forming complexes that inhibit calcineurin (Liu et al., 1991, 4116 citations). This prevents NFAT dephosphorylation and nuclear translocation, halting cytokine gene transcription (Hogan et al., 2003, 1948 citations). Over 10 key papers from 1991-2005 establish this pathway's core biochemistry (Rusnak and Mertz, 2000, 1362 citations).
Why It Matters
Calcineurin inhibition by immunophilin-drug complexes forms the basis of immunosuppressive therapy in organ transplantation and autoimmune diseases like rheumatoid arthritis. Liu et al. (1991) identified calcineurin as the shared target, enabling cyclosporin A and FK506 clinical use. Ho et al. (1996) detailed downstream NFAT blockade, explaining efficacy in preventing graft rejection. Buono et al. (1992) confirmed T-lymphocyte specificity, guiding dosing for minimal toxicity.
Key Research Challenges
Drug Binding Selectivity
Achieving selective inhibition of calcineurin without off-target effects remains difficult due to immunophilin ubiquity. Wang and Heitman (2005) highlight cyclophilin isoforms complicating specificity. Liu et al. (1992) note FK506-FKBP complexes' variable phosphatase binding kinetics.
Resistance in Pathogens
Cryptococcus neoformans develops calcineurin-dependent virulence resistant to standard inhibitors. Odom et al. (1997) show essentiality for fungal survival, challenging antifungal design. Rusnak and Mertz (2000) describe structural barriers to eukaryotic selectivity.
Downstream Pathway Variability
NFAT regulation varies across cell types, impacting therapeutic predictability. Hogan et al. (2003) detail calcium-dependent transcriptional control differences. Ho et al. (1996) report inconsistent cytokine suppression in non-T cells.
Essential Papers
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Jun S. Liu, Jesse D. Farmer, Willam S. Lane et al. · 1991 · Cell · 4.1K citations
Transcriptional regulation by calcium, calcineurin, and NFAT
Patrick G. Hogan, Lin Chen, Julie Nardone et al. · 2003 · Genes & Development · 1.9K citations
The NFAT family of transcription factors encompasses five proteins evolutionarily related to the Rel/NF B family (Chytil and Verdine 1996; Graef et al. 2001b). The primordial family member is NFAT5...
Calcineurin: Form and Function
Frank Rusnak, Pamela Mertz · 2000 · Physiological Reviews · 1.4K citations
Calcineurin is a eukaryotic Ca 2+ - and calmodulin-dependent serine/threonine protein phosphatase. It is a heterodimeric protein consisting of a catalytic subunit calcineurin A, which contains an a...
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
Roberta Buono, Claude B. Klee, Barbara E. Bierer et al. · 1992 · Proceedings of the National Academy of Sciences · 815 citations
The immunosuppressive agents cyclosporin A (CsA) and FK 506 bind to distinct families of intracellular proteins (immunophilins) termed cyclophilins and FK 506-binding proteins (FKBPs). Recently, it...
The Mechanism of Action of Cyclosporin A and FK506
Steffan N. Ho, Neil A. Clipstone, Luika Timmermann et al. · 1996 · Clinical Immunology and Immunopathology · 676 citations
The immunosuppressants cyclosporin A (CsA), FK506, and rapamycin suppress the immune response by inhibiting evolutionary conserved signal transduction pathways. CsA, FK506, and rapamycin bind to th...
Drug target validation and identification of secondary drug target effects using DNA microarrays
Matthew J. Marton, Joseph L. DeRisi, Holly A. Bennett et al. · 1998 · Nature Medicine · 647 citations
Regulated necrosis: disease relevance and therapeutic opportunities
Marcus Conrad, José Pedro Friedmann Angeli, Peter Vandenabeele et al. · 2016 · Nature Reviews Drug Discovery · 602 citations
Reading Guide
Foundational Papers
Start with Liu et al. (1991) for core target discovery, then Rusnak and Mertz (2000) for calcineurin structure, followed by Buono et al. (1992) for T-cell validation.
Recent Advances
Wang and Heitman (2005) on cyclophilin family; Conrad et al. (2016) links to regulated necrosis pathways.
Core Methods
Phosphatase activity assays, co-precipitation for complexes, NFAT dephosphorylation gels (Liu et al., 1992; Ho et al., 1996).
How PapersFlow Helps You Research Immunophilins in Calcineurin Inhibition
Discover & Search
Research Agent uses searchPapers('immunophilin calcineurin inhibition cyclosporin') to retrieve Liu et al. (1991) as top hit (4116 citations), then citationGraph to map 50+ citing works on FKBP complexes, and findSimilarPapers to uncover related NFAT studies like Hogan et al. (2003). exaSearch scans abstracts for 'cyclophilin-cyclosporin A binding kinetics' yielding Buono et al. (1992).
Analyze & Verify
Analysis Agent applies readPaperContent on Liu et al. (1991) to extract binding assays, then verifyResponse with CoVe against Rusnak and Mertz (2000) for phosphatase heterodimer claims. runPythonAnalysis parses IC50 data from multiple papers into pandas for statistical comparison of cyclosporin vs FK506 potency. GRADE grading scores evidence as A-level for T-cell inhibition (Buono et al., 1992).
Synthesize & Write
Synthesis Agent detects gaps in selectivity data across Wang and Heitman (2005) cyclophilin isoforms via gap detection, flags contradictions in NFAT models (Hogan et al., 2003 vs Ho et al., 1996). Writing Agent uses latexEditText to draft pathway reviews, latexSyncCitations for 10-paper bibliographies, and latexCompile for figure-inclusive manuscripts; exportMermaid generates calcineurin inhibition flowcharts.
Use Cases
"Plot IC50 curves for cyclosporin A vs FK506 on calcineurin from primary literature."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (NumPy/matplotlib on extracted data from Liu et al. 1991 and Liu et al. 1992) → researcher gets overlaid dose-response plots with statistics.
"Write LaTeX review of immunophilin-Calcineurin-NFAT axis with figures."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Ho et al. 1996, Hogan et al. 2003) + latexGenerateFigure + latexCompile → researcher gets compiled PDF with citations and pathway diagram.
"Find code for modeling cyclophilin-drug binding kinetics."
Research Agent → paperExtractUrls (on Rusnak and Mertz 2000) → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for molecular dynamics simulations of FKBP-FK506.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ on 'FKBP calcineurin') → citationGraph → GRADE all claims → structured report on inhibition mechanisms. DeepScan applies 7-step analysis with CoVe checkpoints to verify Liu et al. (1991) target claims against 1992-2005 papers. Theorizer generates hypotheses on isoform-specific inhibitors from Wang and Heitman (2005) cyclophilin data.
Frequently Asked Questions
What defines immunophilins in calcineurin inhibition?
Immunophilins are cyclophilins and FKBPs that, when bound to cyclosporin A or FK506, form complexes inhibiting calcineurin phosphatase (Liu et al., 1991).
What are key methods for studying these complexes?
In vitro phosphatase assays measure activity loss; co-immunoprecipitation confirms binding (Buono et al., 1992; Liu et al., 1992).
What are the highest-cited papers?
Liu et al. (1991, 4116 citations) identifies calcineurin as common target; Hogan et al. (2003, 1948 citations) details NFAT regulation.
What open problems exist?
Selectivity across cyclophilin isoforms and resistance in pathogens like Cryptococcus (Wang and Heitman, 2005; Odom et al., 1997).
Research Signaling Pathways in Disease with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Immunophilins in Calcineurin Inhibition with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Signaling Pathways in Disease Research Guide